Freeline to Present at Upcoming Investor Conferences

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Freeline Announces July 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline Reports Half Year 2020 Financial Results and Recent Business Highlights
New England Journal of Medicine Publishes Positive Long-Term Data on Freeline’s Gene Therapy Candidate FLT180a for People with Hemophilia B
Freeline Reports Second Quarter 2022 Financial Results and Business Highlights
Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels